Alnylam Pharma(MX:ALNY)
MX$2,950.00+40.00 (+1.37%)
MX:ALNY
Alnylam Pharma earnings date
MX$2,950.00
At close:+40.00 (+1.37%)
Alnylam Pharma (ALNY) Q3 2020 Earnings Report
0 Followers
MX:ALNY Q3 2020 EPS Results
- Actual EPS
- -MXN 40.55
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 35.71
MX:ALNY Q3 2020 Revenue Results
- Actual Revenue
- MXN 2.34B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +79.63%
Earnings Announcement Details
- Quarter
- Q3 2020
- Date
- 11/05/2020
- Time
- Before Open
- Conference Call
- Thursday, November 5, 2020
MX:ALNY Upcoming Earnings
Alnylam Pharma's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q3 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ALNY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 32.01- | 15.25 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 30.88292.39 | 34.22 | 754.35% (+258.17) | |
| Jul 30, 2026 | 2026 (Q2) | 30.3222.51 | -9.49 | 337.25% (+31.99) | |
| Apr 30, 2026 | 2026 (Q1) | 16.2228.09 | -8.18 | 443.18% (+36.27) | |
| Feb 12, 2026 | 2025 (Q4) | 21.3915.25 | -12.09 | 226.15% (+27.34) | |
| Oct 30, 2025 | 2025 (Q3) | 10.4334.22 | -16.18 | 311.49% (+50.41) | |
| Jul 31, 2025 | 2025 (Q2) | -10.12-9.49 | -2.42 | -292.31% (-7.07) | |
| May 01, 2025 | 2025 (Q1) | -16.55-8.18 | -9.67 | 15.38% (+1.49) | |
| Feb 13, 2025 | 2024 (Q4) | -11.01-12.09 | -20.46 | 40.91% (+8.37) | |
| Oct 31, 2024 | 2024 (Q3) | -17.06-16.18 | 21.39 | -175.65% (-37.57) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
